Omega Fund Management, LLC Top Holdings and 13F Report (2024)

→ Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad)

About Omega Fund Management, LLC

Omega Fund Management, LLC has $155.01 million in total holdings as of March 31, 2024.
Omega Fund Management, LLC owns shares of 11 different stocks, but just 4 companies or ETFs make up 80% of its holdings.
Approximately 2.01% of the portfolio was purchased this quarter.
About 15.16% of the portfolio was sold this quarter.
This quarter, Omega Fund Management, LLC has purchased 14 new stocks and bought additional shares in 1 stock.
Omega Fund Management, LLC sold shares of 5 stocks and completely divested from 3 stocks this quarter.

Morphic: 150,000 shares (about $5.28M)
Kronos Bio: 2,862,417 shares (about $3.72M)
Nuvation Bio: 1,000,000 shares (about $3.64M)
enGene Holdings Inc.: 54,818 shares (about $929.17K)
enGene Holdings Inc.: 114,174 shares (about $593.70K)

Selling

Neutral

Buying

Issuer Name	Holdings Value	Approximate Purchase/Sale	Change in Shares	Shares Held	% of Portfolio	Sector
NUVB Nuvation Bio	$51,223,318	$3,640,000 ▼	-6.6%	14,072,340	33.0%	Medical
Lexeo Therapeutics	$36,940,575	$3,109,046 ▲	9.2%	2,355,904	23.8%	Common Stock
REPL Replimune Group	$24,520,776		0.0%	3,001,319	15.8%	Medical
enGene Holdings Inc.	$18,244,251	$929,165 ▼	-4.8%	1,076,357	11.8%	Common Stock
SANA Sana Biotechnology	$8,437,500		0.0%	843,750	5.4%	Medical
MORF Morphic	$5,626,579	$5,280,000 ▼	-48.4%	159,846	3.6%	Medical
IKNA Ikena Oncology	$3,193,755		0.0%	2,249,123	2.1%	Medical
IMUX Immunic	$2,360,371		0.0%	1,788,160	1.5%	Medical
enGene Holdings Inc.	$1,876,696	$593,705 ▼	-24.0%	360,903	1.2%	Warrant
SYRS Syros Pharmaceuticals	$1,344,295		0.0%	251,270	0.9%	Medical
KRON Kronos Bio	$1,242,626	$3,721,143 ▼	-75.0%	955,866	0.8%	Medical
SPRB Spruce Biosciences	$0	$6,331,794 ▼	-100.0%	0	0.0%	Medical
THRX Theseus Pharmaceuticals	$0	$2,881,490 ▼	-100.0%	0	0.0%	Medical
SNTI Senti Biosciences	$0	$129,223 ▼	-100.0%	0	0.0%	Medical